Novel LanT associated lantibiotic clusters identified by genome database mining

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Singh, Mangal ^a   Sareen, Dipti ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; HALODURACIN; LANTIBIOTIC; LANTIBIOTIC LANT; LICHENICIDIN; MERSACIDIN; SALIVARICIN; UNCLASSIFIED DRUG; ALANINE; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; LANTHIONINE; SULFIDE;

ANTIBIOTIC BIOSYNTHESIS; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BIOINFORMATICS; CLUSTER ANALYSIS; DATA MINING; GENE CLUSTER; GENE IDENTIFICATION; GENOME ANALYSIS; NONHUMAN; SEQUENCE ANALYSIS; ACTINOBACTERIA; ANALOGS AND DERIVATIVES; BACTERIAL GENE; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; GENETIC DATABASE; GENETICS; GENOMICS; IMMUNOLOGY; METABOLISM; MULTIGENE FAMILY; QUORUM SENSING; TRANSPORT AT THE CELLULAR LEVEL;

ACTINOBACTERIA; ALANINE; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT; DATA MINING; DATABASES, GENETIC; GENES, BACTERIAL; GENOMICS; MULTIGENE FAMILY; QUORUM SENSING; SULFIDES;

EID: 84898007815     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091352     Document Type: Article

References (54)

1. Tomasz A (1994) Muliple-antibiotic resistant pathogenic bacteria. N Engl J Med 330: 1247-1251.
2. Mattick ATR, Hirsch A (1944) A powerful inhibitory substance produced by group N Streptococci. Nature 154: 551.
3. Delves-Broughton J, Blackburn P, Evans RJ, Hugenholtz J (1996) Application of bacteriocin nisin. Antonie Van Leeuwenhoek 69: 193-202.
4. Wiedemann I, Breukink E, van Kraaij C, Kuipers OP, Bierbaum G, et al. (2001) Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem 276: 1772-1779. (Pubitemid 32109649)
5. Brötz H, Josten M, Wiedemann I, Schneider U, Götz F, et al. (1998) Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol Microbiol 30: 317-327. (Pubitemid 28480183)
6. Patton GC, Paul M, Cooper LE, Chatterjee C, van der Donk WA (2008) The importance of leader sequence for directing lanthionine formation in lacticin 481. Biochemistry 47: 7342-7351. (Pubitemid 351991013)
7. Li B, Yu JPJ, Brunzelle JS, Moll GN, van der Donk WA, et al. (2006) Structure and mechanism of the lantibiotic cyclase involved in nisin biosynthesis. Science 311: 1464-1467. (Pubitemid 43376701)
8. Xie L, Miller LM, Chatterjee C, Averin O, Kelleher NL, et al. (2004) Lacticin 481: in vitro reconstitution of lantibiotic synthetase activity. Science 303: 679-681. (Pubitemid 38141635)
9. Kuipers A, de Boef E, Rink R, Fekken S, Kluskens LD, et al. (2004) NisT, the transporter of the lantibiotic nisin, can transport fully modified, dehydrated, and unmodified prenisin and fusions of the leader peptide with non-lantibiotic peptides. J Biol Chem 279: 22176-22182. (Pubitemid 38679411)
10. Izaguirre G, Hansen JN (1997) Use of alkaline phosphatase as a reporter polypeptide to study the role of the subtilin leader segment and the SpaT transporter in the posttranslational modifications and secretion of subtilin in Bacillus subtilis 168. Appl Environ Microbiol 63: 3965-3971. (Pubitemid 27411355)
11. Håvarstein LS, Diep DB, Nes IF (1995) A family of bacteriocin ABC transporters carry out proteolytic processing of their substrates concomitant with export. Mol Microbiol 16: 229-240.
12. Corvey C, Stein T, Düsterhus S, Karas M, Entian K-D (2003) Activation of subtilin precursors by Bacillus subtilis extracellular serine proteases subtilisin (AprE), WprA, and Vpr. Biochem Biophys Res Commun 304: 48-54. (Pubitemid 36434192)
13. Altena K, Guder A, Cramer C, Bierbaum G (2000) Biosynthesis of the lantibiotic mersacidin: organization of a type B lantibiotic gene cluster. Appl Environ Microbiol 66: 2565-2571. (Pubitemid 30353966)
14. Cotter PD, Hill C, Ross RP (2005) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3: 777-788. (Pubitemid 41518738)
15. Nes IF, Diep DB, Holo H (2007) Bacteriocin diversity in Streptococcus and Enterococcus. J Bacteriol 189: 1189-1198. (Pubitemid 46239740)
16. Klaenhammer TR (1993) Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev 12: 39-85.
17. Arnison PG, Bibb MJ, Bierbaum G, Bowers A, Bugni TS, et al. (2013) Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep 30: 108-160.
18. De Jong A, van Heel AJ, Kok J, Kuipers OP (2010) BAGEL2: mining for bacteriocins in genomic data. Nucleic Acids Res 38: W647-W651.
19. Willey JM, van der Donk WA (2007) Lantibiotics: peptides of diverse structure and function. Annu Rev Microbiol 61: 477-501. (Pubitemid 350058218)
20. Lubelski J, Rink R, Khusainov R, Moll GN, Kuipers OP (2008) Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin. Cell Mol Life Sci 65: 455-476. (Pubitemid 351214649)
21. Foulston LC, Bibb MJ (2010) Microbisporicin gene cluster reveals unusual features of lantibiotic biosynthesis in actinomycetes. Proc Natl Acad Sci U S A 107: 13461-13466.
22. Goto Y, Li B, Claesen J, Shi Y, Bibb MJ, et al. (2010) Discovery of unique lanthionine synthetases reveals new mechanistic and evolutionary insights. PLoS Biol 8: e1000339.
23. Kleerebezem M, Quadri LE, Kuipers OP, de Vos WM (1997) Quorum sensing by peptide pheromones and two-component signal-transduction systems in Gram-positive bacteria. Mol Microbiol 24: 895-904. (Pubitemid 27286143)
24. Alkhatib Z, Abts A, Mavaro A, Schmitt L, Smits SHJ (2012) Lantibiotics: how do producers become self-protected? J Biotechnol 159: 145-154.
25. Stein T, Heinzmann S, Solovieva I, Entian K-D (2003) Function of Lactococcus lactis nisin immunity genes nisI and nisFEG after coordinated expression in the surrogate host Bacillus subtilis. J Biol Chem 278: 89-94. (Pubitemid 36043548)
26. Brötz H, Bierbaum G, Markus A, Molitor E, Sahl HG, et al. (1995) Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism? Antimicrob Agents Chemother 39: 714-719.
27. McClerren AL, Cooper LE, Quan C, Thomas PM, Kelleher NL, et al. (2006) Discovery and in vitro biosynthesis of haloduracin, a two-component lantibiotic. Proc Natl Acad Sci U S A 103: 17243-17248. (Pubitemid 44788954)
28. Lawton EM, Cotter PD, Hill C, Ross RP (2007) Identification of a novel two-peptide lantibiotic, haloduracin, produced by the alkaliphile Bacillus halodurans C-125. FEMS Microbiol Lett 267: 64-71. (Pubitemid 46066541)
29. Dischinger J, Josten M, Szekat C, Sahl H-G, Bierbaum G (2009) Production of the novel two-peptide lantibiotic lichenicidin by Bacillus licheniformis DSM 13. PLoS One 4: e6788.
30. Begley M, Cotter PD, Hill C, Ross RP (2009) Identification of a novel two-peptide lantibiotic, lichenicidin, following rational genome mining for LanM proteins. Appl Environ Microbiol 75: 5451-5460.
31. Cox CR, Coburn PS, Gilmore MS (2005) Enterococcal cytolysin: a novel two component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells. Curr Protein Pept Sci 6: 77-84. (Pubitemid 40259803)
32. Li B, Sher D, Kelly L, Shi Y, Huang K, et al. (2010) Catalytic promiscuity in the biosynthesis of cyclic peptide secondary metabolites in planktonic marine cyanobacteria. Proc Natl Acad Sci U S A 107: 10430-11435.
33. Yu C, Chen Y, Lu C, Hwang J (2006) Prediction of protein subcellular localization. Proteins 64: 643-651. (Pubitemid 44100730)
34. Wang G, Li X, Wang Z (2009) APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res 37: D933-D937.
35. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739.
36. Xiong Z, Jiang Y, Qi D, Lu H, Yang F, et al. (2009) Complete genome sequence of the extremophilic Bacillus cereus strain Q1 with industrial applications. J Bacteriol 191: 1120-1121.
37. Wakamiya T, Ueki Y, Shiba T, Kido Y, Motoki Y (1985) The structure of ancovenin, a new peptide inhibitor of angiotensin I converting enzyme. Tetrahedron Lett 26: 665-668. (Pubitemid 15169253)
38. Fredenhagen A, Fendrich G, Marki F, Marki W, Gruner J, et al. (1990) Duramycins B and C, two new lanthionine containing antibiotics as inhibitors of phospholipase A2. Structural revision of duramycin and cinnamycin. J Antibiot (Tokyo) 43: 1403-1412. (Pubitemid 20378498)
39. Wang X-J, Yan Y-J, Zhang B, An J, Wang J-J, et al. (2010) Genome sequence of the milbemycin-producing bacterium Streptomyces bingchenggensis. J Bacteriol 192: 4526-4527.
40. Kataeva I a, Yang S-J, Dam P, Poole FL, Yin Y, et al. (2009) Genome sequence of the anaerobic, thermophilic, and cellulolytic bacterium "Anaerocellum thermophilum" DSM 6725. J Bacteriol 191: 3760-3761.
41. He Z, Yuan C, Zhang L, Yousef AE (2008) N-terminal acetylation in paenibacillin, a novel lantibiotic. FEBS Lett 582: 2787-2792.
42. Chang Y-J, Land M, Hauser L, Chertkov O, Del Rio TG, et al. (2011) Noncontiguous finished genome sequence and contextual data of the filamentous soil bacterium Ktedonobacter racemifer type strain (SOSP1-21). Stand Genomic Sci 5: 97-111.
43. Marsh AJ, O'Sullivan O, Ross RP, Cotter PD, Hill C (2010) In silico analysis highlights the frequency and diversity of type 1 lantibiotic gene clusters in genome sequenced bacteria. BMC Genomics 11: 679.
44. Wang H, Fewer DP, Sivonen K (2011) Genome mining demonstrates the widespread occurrence of gene clusters encoding bacteriocins in cyanobacteria. PLoS One 6: e22384.
45. Dirix G, Monsieurs P, Dombrecht B, Daniels R, Marchal K (2004) Peptide signal molecules and bacteriocins in Gram-negative bacteria: a genome-wide screening for peptides containing a double-glycine leader sequence and their cognate transporters. Peptides 25: 1425-1440. (Pubitemid 39221526)
46. Li X, O'Sullivan DJ (2012) Contribution of the actinobacteria to the growing diversity of lantibiotics. Biotechnol Lett 34: 2133-2145.
47. Upton M, Tagg JR, Wescombe P, Jenkinson HF (2001) Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides. J Bacteriol 183: 3931-3938. (Pubitemid 32565472)
48. Plat A, Kluskens LD, Kuipers A, Rink R, Moll GN (2011) Requirements of the engineered leader peptide of nisin for inducing modification, export, and cleavage. Appl Environ Microbiol 77: 604-611.
49. Stepper J, Shastri S, Loo TS, Preston JC, Novak P, et al. (2011) Cysteine Sglycosylation, a new post-translational modification found in glycopeptide bacteriocins. FEBS Lett 585: 645-650.
50. Nusspaumer G, Remacha M, Ballesta JP (2000) Phosphorylation and N-terminal region of yeast ribosomal protein P1 mediate its degradation, which is prevented by protein P2. EMBO J 19: 6075-6084.
51. Hyink O, Balakrishnan M, Tagg JR (2005) Streptococcus rattus strain BHT produces both a class I two-component lantibiotic and a class II bacteriocin. FEMS Microbiol Lett 252: 235-241. (Pubitemid 41531649)
52. Yonezawa H, Kuramitsu HK (2005) Genetic analysis of a unique bacteriocin, Smb, produced by Streptococcus mutans GS5. Antimicrob Agents Chemother 49: 541-548. (Pubitemid 40175659)
53. Ryan MP, Rea MC, Hill C, Ross RP (1996) An application in cheddar cheese manufacture for a strain of Lactococcus lactis producing a novel broad-spectrum bacteriocin, lacticin 3147. Appl Environ Microbiol 62: 612-619.
54. Navaratna MADB, Sahl H, John R (1998) Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol 64: 4803-4808. (Pubitemid 28557842)